Imeglimin Hydrochloride Tablets 500 MG – IGLYN 500 Tablets

IGLYN 500 Tablets – Next-Generation Oral Therapy for Type 2 Diabetes Care.

IGLYN 500 Tablets – Imeglimin Hydrochloride Tablets 500 MG is a first-in-class Glimin oral antidiabetic medication, specifically formulated for treating Type 2 diabetes mellitus. It works by a dual mechanism of action, enhancing insulin secretion and promoting insulin sensitivity, making it a unique glin-class agent. Improving mitochondrial function in the liver and muscle ensures balanced glycemic control with minimal side effects. Imeglimin can be prescribed both as monotherapy and in combination therapy with other antidiabetic agents.

Key Benefits of Imeglimin Hydrochloride 500 mg – IGLYN 500 Tablets
✅ First-in-Class Glimin Derivative – As it is unique in class and action, it works across liver, muscle, and pancreatic tissues to reduce glucose output and improve glucose uptake.
✅ Dual Targeted Action – Enhances β-cell activity and insulin sensitivity while optimizing mitochondrial bioenergetics.
✅ Safe & Well-Tolerated – Low risk of hypoglycemia, no major weight gain, suitable for early-stage therapy and long-term use.

Recommended By Specialists:
👨‍⚕️ Diabetologists & Endocrinologists: For comprehensive diabetes care and insulin resistance management.
👨‍⚕️ General Physicians: For early detection and long-term control of Type 2 Diabetes.

INDICATIONS:
✅ Type 2 Diabetes Mellitus
✅ Insulin Resistance & Metabolic Dysfunction
✅ Add-on Therapy with Metformin or DPP-4 Inhibitors
✅ Early-Stage Diabetes Management
✅ Preservation of β-cell Function